Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
There is limited evidence of the effectiveness of the CoronaVac vaccine for children against the Omicron SARS-CoV-2 variant. Here, the authors use data from Brazil for children aged 6–11 years and estimate effectiveness of 40% against infection and 59% against severe disease at least two weeks after...
Main Authors: | Pilar T. V. Florentino, Flávia J. O. Alves, Thiago Cerqueira-Silva, Vinicius de Araújo Oliveira, Juracy B. S. Júnior, Adelson G. Jantsch, Gerson O. Penna, Viviane Boaventura, Guilherme L. Werneck, Laura C. Rodrigues, Neil Pearce, Manoel Barral-Netto, Mauricio L. Barreto, Enny S. Paixão |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-32524-5 |
Similar Items
-
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
by: Samar Samoud, et al.
Published: (2023-08-01) -
BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac
by: Çiğdem Erol, et al.
Published: (2023-07-01) -
Humoral Immune Response to CoronaVac in Turkish Adults
by: Yasemin Cosgun, et al.
Published: (2023-01-01) -
ANCA-associated vasculitis following the CoronaVac vaccination
by: Yaohui Ma, et al.
Published: (2022-11-01) -
Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers
by: Gulsum Iclal Bayhan, et al.
Published: (2022-01-01)